Melbourne biotech venture CNSDose secures $1m from two angel investors

Visual of CNSDose homepage. July 2016.

Melbourne biotech startup venture CNSDose has closed a seed investment of nearly $1 million from two angel investors. CNSDose seeks to refine how antidepressants are prescribed to individual patients through the use of a genomic test.

In addition to securing funding, the former Australian federal trade minister Andrew Robb is joining the venture’s advisory board. The former head of the psychiatry department at the University of Melbourne, John Tiller, and US medical technology investor Mark Heinemeyer, are already serving as advisors to CNSDose.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter